Serum Biotec Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.83 M
- Company Age 27 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -42.23%
- Profit Growth -110.58%
- Ebitda 2407.63%
- Net Worth -12.35%
- Total Assets -55.65%
About Serum Biotec
Serum Biotec Limited (SBL) is a Public Limited Indian Non-Government Company incorporated in India on 24 October 1997 and has a history of 27 years and three months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M, as per Ministry of Corporate Affairs (MCA) records.
Lata Kothari, Dinesh Kothari, and Revati Kothari serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U00304PN1997PLC128396
-
Company No.
128396
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
24 Oct 1997
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Serum Biotec Limited offer?
Serum Biotec Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Injectable Products, HIV Drugs, Tenofovir Tablet, Docetaxel Injection, Immunomodulator Drugs, Normal Immunoglobulin Injection, Trastuzumab Injections, Vaccines.
Who are the key members and board of directors at Serum Biotec?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Kothari
|
Managing Director | 24-Oct-1997 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Lata Kothari
|
Director | 06-Sep-2004 | Current |
|
Revati Kothari
|
Additional Director | 27-Sep-2021 | Current |
Financial Performance of Serum Biotec.
Serum Biotec Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 42.23% decrease. The company also saw a substantial fall in profitability, with a 110.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serum Biotec?
In 2019, Serum Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nootan Pharmaceutical Private LimitedLata Kothari and Dinesh Kothari are mutual person
-
Dawabag Private LimitedLata Kothari, Dinesh Kothari and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Serum Biotec?
Unlock and access historical data on people associated with Serum Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serum Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serum Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
